The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
about
Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine NeuronsParkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells.Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophyHigh Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's DiseaseRescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration.ROS Production and ERK Activity Are Involved in the Effects of d-β-Hydroxybutyrate and Metformin in a Glucose Deficient ConditionAberrant autophagy and parkinsonism: does correction rescue from disease progression?Activation of the 5'-AMP-Activated Protein Kinase in the Cerebral Cortex of Young Senescence-Accelerated P8 Mice and Association with GSK3β- and PP2A-Dependent Inhibition of p-tau₃₉₆ Expression.Therapeutic potential of autophagy-enhancing agents in Parkinson's disease.Effects of Alpha-Synuclein on Primary Spinal Cord Neurons Associated with Apoptosis and CNTF Expression.Knockdown of α-synuclein in cerebral cortex improves neural behavior associated with apoptotic inhibition and neurotrophin expression in spinal cord transected rats.AMPK in Neurodegenerative Diseases.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease.Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington's Disease.Metformin Protects Cells from Mutant Huntingtin Toxicity Through Activation of AMPK and Modulation of Mitochondrial Dynamics.Modulating the catalytic activity of AMPK has neuroprotective effects against α-synuclein toxicity.Metformin Inhibits the Development of L-DOPA-Induced Dyskinesia in a Murine Model of Parkinson's Disease.Tauroursodeoxycholic Acid Protects Against Mitochondrial Dysfunction and Cell Death via Mitophagy in Human Neuroblastoma Cells.Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia.Novel Neuroprotective Effects of Melanin-Concentrating Hormone in Parkinson's Disease.Glucose Metabolism and AMPK Signaling Regulate Dopaminergic Cell Death Induced by Gene (α-Synuclein)-Environment (Paraquat) Interactions.Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease.The Therapeutic Potential of Metformin in Neurodegenerative Diseases
P2860
Q28553200-4D0195F1-365B-4731-ABB4-5A54065C517FQ33797449-2FB36892-EF92-4974-B51E-193D72745918Q34795775-E05FD92F-8B78-4872-B3D3-EBF648EA1655Q35627057-82301FCA-E49E-4AD7-8963-F58E99E9AE76Q35771016-2312EA1A-9197-4322-888A-645ACFAF4C39Q36665912-91F5C847-7050-4022-87A0-465C14981BD1Q37701985-574288BD-92FE-4399-B618-BFB0DC75D782Q37729364-9B40DF52-C5C5-4E42-8AB7-4F0FF6249069Q38212199-B33154C0-1064-45A4-8CFA-EE5B2AD0F1D1Q38428126-A40DF4DC-D83F-44C9-9609-988664FF9704Q38765856-37C5670A-A54E-4D53-92BB-453EDE77F7BEQ38825717-73D391F1-206A-4016-86DD-434181904CE8Q38914810-F5DFA26D-E121-43AB-A10D-96A8ACFBE1D5Q38998405-BF1FECAD-AC59-40D6-A45E-624D7AAF9B7AQ39199926-1E2F9DB7-F84C-4444-A680-284E7B30DF63Q42142638-57E9A9CE-B4DE-4473-A816-1EF0DDF0052AQ42228159-6D1FBAEF-E4F7-43E6-A967-D287E0EE74B8Q45827373-3B4250C9-41ED-4A1A-A0B5-DF151F2374E8Q47988278-CD0BAD78-1935-41EA-8F82-907DB7407A9AQ48177380-A4B8651A-7F1C-42BC-A915-692123CEDD3DQ48282700-80A447F8-9061-4351-AE4D-C081479BBF95Q48451001-EEB25211-3249-4A02-AC5E-F075EBF7761EQ51100537-7FD7E643-FCB4-4DD9-AC22-D0DD4330E851Q51691934-C6FBABFB-9DE5-4696-B82B-9AA5371E3F21Q52609727-1AA2D3AE-2CDD-4E8A-825C-6809841613EEQ57175337-11DEEB7C-8D7F-4BA6-A725-F356580A1C57
P2860
The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The protective role of AMP-act ...... uclein neurotoxicity in vitro.
@en
The protective role of AMP-act ...... uclein neurotoxicity in vitro.
@nl
type
label
The protective role of AMP-act ...... uclein neurotoxicity in vitro.
@en
The protective role of AMP-act ...... uclein neurotoxicity in vitro.
@nl
prefLabel
The protective role of AMP-act ...... uclein neurotoxicity in vitro.
@en
The protective role of AMP-act ...... uclein neurotoxicity in vitro.
@nl
P2093
P50
P1476
The protective role of AMP-act ...... nuclein neurotoxicity in vitro
@en
P2093
Leonidas Stefanis
Maja Jovanovic
Maria Xilouri
Marija Dulovic
Mustafa T Ardah
Omar M A El-Agnaf
Vladimir Kostic
Vladimir Trajkovic
P356
10.1016/J.NBD.2013.11.002
P50
P577
2013-11-20T00:00:00Z